The tissue is the issue: personalized medicine for non-small cell lung cancer
The development of molecular markers is crucial for improving therapy in advanced non-small cell lung cancer (NSCLC). Here, we review perspectives of biomarker-driven personalized therapy in NSCLC, with particular reference to the detection of EML4-ALK gene rearrangements. Different molecular assays...
Saved in:
Published in | Clinical cancer research Vol. 16; no. 20; pp. 4909 - 4911 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.10.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!